The Price Is (Finally) Right

By Derek Bagley

April 10, 2023

Recent insulin price cuts are a dose of good news. In March, Eli Lilly lowered the price on its most popular insulins, with Novo Nordisk and Sanofi following suit shortly thereafter, but only after the $35 monthly price cap for people on Medicare that was mandated by the Inflation Reduction Act. Is this the […]

To view the full Member Resource, please Log in

TOPICS IN THIS ARTICLE:

Join the Global Movement Advancing Endocrine Science and Medicine

Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.

Join Today

RELATED ARTICLES

Heroin Adulterated with Diabetes Medication Triggers Life-Threatening Medical Emergencies

Hyperinsulinemia Emerges as Critical Predictor of Severe Liver Outcomes

Father’s Tobacco Use May Raise Children’s Diabetes Risk

Health Topics

Patient Populations